Gujarat Kidney and Tremendous Speciality IPO Information: Gujarat Kidney and Tremendous Specialty (Gujarat Kidney and Tremendous Speciality) has filed a preliminary paperwork with the preliminary paperwork to lift funds via the Preliminary Public Inu (IPO) for acquisition and enlargement. The IPO will embody new problems with solely 2.2 crore fairness shares. Wherein there can be no supply on the market. Subsequently, in accordance with the DRHP filed on March 28, your complete revenue from the IPO will get to the corporate. Gujarat -based healthcare firm has six medium -sized multispeciality hospitals and three pharmacy with a 250 -bed working capability. Guzrat Kidney and Tremendous Specialty has deliberate to spend Rs 77 crore from Rs 77 crore from pure recent points for the proposed acquisition of Parekhs Hospital in Ahmedabad. Other than this, it’s deliberate to spend Rs 12.4 crore for partial cost of already bought Ashwini Medical Heart. Bulk & Block Offers: ZOMATO and HAL can be purchased by Goldman Sachs in ZOMATO and HAL, along with this, large offers associated information in these firms may also be set as much as arrange a brand new hospital. Together with this, Rs 7.28 crore can be accomplished in buying robotics gear. Whereas Rs 1.5 crore can be used to repay the mortgage. The remaining IPO funds can be used for inorganic development and normal company functions. Within the final monetary 12 months 2024-25, the corporate recorded a revenue of Rs 1.71 crore on a income of Rs 4.77 crore within the final monetary 12 months 2024-25. Other than this, the revenue on the income of Rs 18.67 crore within the six -month interval ended September 2024 was Rs 5.63 crore. Nirbhay Capital Companies have been appointed as a service provider banker for Gujarat Kidney and Tremendous Specialty IPO. Earlier than making use of cash as an investor is at all times consulted by the specialists.
Supply hyperlink
